AON怡安智库：2026年全球医疗趋势报告

Core Insights - The AON Global Healthcare Trend Report 2026 predicts a global average healthcare inflation rate of 9.8%, returning to single digits but still driven by factors such as increased healthcare service usage, technological advancements, rising private healthcare demand, and an aging population [10][11][12]. Global Overview - North America and Asia-Pacific are the only regions expected to see an increase in healthcare inflation rates, projected at 9.3% and 11.3% respectively, while other regions like Europe, Latin America, and the Middle East and Africa are experiencing a decline [13][15]. - The Middle East and Africa region has the highest inflation rate at 15.3%, despite a slight decrease from the previous year [15][16]. - The report emphasizes the importance of regional trends and the internal conditions driving inflation rate changes, as well as the strategies companies are adopting to mitigate rising costs [11][12]. Disease-Driven Costs - Cardiovascular diseases, cancer, and hypertension are identified as the top three drivers of healthcare costs, with musculoskeletal diseases entering the top five for the first time [19][20]. - GLP-1 medications, widely approved for diabetes treatment and weight loss, contribute approximately 10% to the healthcare trend growth rate, with some markets seeing contributions as high as 25% [24][25]. Corporate Strategies - Over 70% of multinational companies prioritize cost control in their benefits plans, employing strategies such as renegotiating with suppliers, initiating tenders, and implementing health promotion programs [17][33]. - Health benefits plans are the most common cost control measure, adopted by 86% of countries, while flexible benefits plans are gaining popularity due to their cost management and talent attraction advantages [35][36]. China-Specific Trends - China's healthcare inflation rate is projected at 7.8% for 2026, influenced by post-pandemic demand, aging population, and chronic disease prevalence [38][57]. - The report highlights the impact of healthcare reforms, including centralized procurement and DRG/DIP policies, on stabilizing costs in the long term [39][45]. - The increasing prevalence of chronic diseases and the aging population are expected to drive healthcare costs upward, despite short-term stabilization efforts [57][64]. Future Outlook - The report anticipates that healthcare costs will return to a normal upward trajectory due to factors such as chronic disease management pressures and the application of innovative drugs [56][57]. - The introduction of new drug categories in the national insurance and commercial health insurance systems is expected to enhance access to high-value treatments, although it may not significantly reduce costs [66].